Abstract

The aim of the present study was to evaluate the clinical and immunohistopathological findings of invasive micropapillary carcinoma (IMPC) of the breast. In total, 25 patients were included in the present study, all of whom were diagnosed with IMPC. The mammography and ultrasound scanning (US) findings were analysed retrospectively according to the American College of Radiology Breast Imaging Reporting and Data System lexicon. Surgical specimens obtained from the patients were microscopically reviewed in consensus by two pathologists with a specialisation in breast pathology. All the patients presented with palpable lumps in the breast, a high-density irregular mass associated with microcalcifications revealed by mammography and an irregular hypoechoic mass with a spiculated margin revealed by US. Axillary lymph node metastases were identified in 80% of the patients. Immunohistochemical studies revealed the lesions to be highly positive for the oestrogen receptor (ER) and c-erbB-2 (88% and 84%, respectively). Although no significant imaging characteristics were found to distinguish IMPC from typical invasive ductal carcinoma, IMPC resulted in nodal metastases and was highly positive for ER and c-erbB-2. This clinical significance indicates the significance of this entity being recognised by pathologists and surgeons.

Highlights

  • Invasive micropapillary carcinoma (IMPC) of the breast is a morphologically distinct and aggressive variant of invasive ductal carcinoma (IDC), accounting for

  • There was no percentage of the IMPC component within the tumour that was proposed as a criterion for diagnosis [1]

  • Despite only a few studies on IMPC imaging findings being conducted, it has been previously reported that mammography may reveal IMPC as an irregular, speculated or indistinct high‐density mass and that ultrasound scanning (US) may reveal IMPC as an irregular, indistinct or hypoechoic mass [14]

Read more

Summary

Introduction

Invasive micropapillary carcinoma (IMPC) of the breast is a morphologically distinct and aggressive variant of invasive ductal carcinoma (IDC), accounting for

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call